pharmatechoutlook
JULY - 20215TECH OUTLOOKCXO INSIGHTSLAST WORDC O NT E NT SIN F CUS193027Heather Stein, MD, MPH, Vice President, Drug Safety and Pharmacovigilance, Boston Biomedical, Inc., and Amie Goulbourne, MPH, MT(ASCP), Senior Director, Head of Pharmacovigilance Operations, Compliance and Training, Boston Biomedical, Inc.Timothy White, Vice President & Head of Global Digital Commercial, Teva PharmaceuticalsSteve Williamson, Head of Internal Audit for Information Security and Data Privacy, GSKPg 10 - 11Effective Pharmacovigilance Driven by Infrastructure Integration, Cross-Functional Collaboration and Technological AdvancementAvoiding the `Shiny Object' Trap of Digital TransformationIs your Security Program Reducing Business Risk? - Expect More from your Internal Audit Function. TECH OUTLOOKSOLUTION PROVIDERS IN EUROPE - 2021TOP 10PHARMACOVIGILANCEPg 16 - 26
< Page 4 | Page 6 >